A major breakthrough in cancer investigation is arising with the use of VHH fragments to re-engage dysfunctional p53. This crucial cancer inhibitor protein is frequently disabled in several types of tumors, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research